Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Hegazi, R. A.F. Articles by Plevy, S. E. Search for Related Content PubMed PubMed Citation Articles by Hegazi, R. A.F. Articles by Plevy, S. E. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB CARBON MONOXIDE Related Collections Related Article Social Bookmarking                      What's this?

¹ Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261
² Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261
³ Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15261
⁴ Department of Surgery, Transplantation Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215

CORRESPONDENCE Scott E. Plevy: sep1{at}pitt.edu

Heme oxygenase (HO)-1 and its metabolic product carbon monoxide (CO) play regulatory roles in acute inflammatory states. In this study, we demonstrate that CO administration is effective as a therapeutic modality in mice with established chronic colitis. CO administration ameliorates chronic intestinal inflammation in a T helper (Th)1-mediated model of murine colitis, interleukin (IL)-10–deficient (IL-10^–/–) mice. In Th1-mediated inflammation, CO abrogates the synergistic effect of interferon (IFN)- on lipopolysaccharide-induced IL-12 p40 in murine macrophages and alters IFN- signaling by inhibiting a member of the IFN regulatory factor (IRF) family of transcription factors, IRF-8. A specific signaling pathway, not previously identified, is delineated that involves an obligatory role for HO-1 induction in the protection afforded by CO. Moreover, CO antagonizes the inhibitory effect of IFN- on HO-1 expression in macrophages. In macrophages and in Th1-mediated colitis, pharmacologic induction of HO-1 recapitulates the immunosuppressive effects of CO. In conclusion, this study begins to elucidate potential etiologic and therapeutic implications of CO and the HO-1 pathway in chronic inflammatory bowel diseases.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

A toxic gas eases IBD

Heather L. Van Epps
J. Exp. Med. 2005 202: 1615. [Full Text] [PDF]

This article has been cited by other articles:

• Kroening, P. R., Barnes, T. W., Pease, L., Limper, A., Kita, H., Vassallo, R. (2008). Cigarette Smoke-Induced Oxidative Stress Suppresses Generation of Dendritic Cell IL-12 and IL-23 through ERK-Dependent Pathways. J. Immunol. 181: 1536-1547 [Abstract] [Full Text]  
• Vareille, M., Rannou, F., Thelier, N., Glasser, A.-L., de Sablet, T., Martin, C., Gobert, A. P. (2008). Heme Oxygenase-1 Is a Critical Regulator of Nitric Oxide Production in Enterohemorrhagic Escherichia coli-Infected Human Enterocytes. J. Immunol. 180: 5720-5726 [Abstract] [Full Text]  
• Colombel, J.-F., Watson, A. J M, Neurath, M. F (2008). The 10 remaining mysteries of inflammatory bowel disease. Gut 57: 429-433 [Full Text]  
• Gronert, K. (2008). Lipid Autacoids in Inflammation and Injury Responses: A Matter of Privilege. Mol. Interv. 8: 28-35 [Abstract] [Full Text]  
• Dave, S. H., Tilstra, J. S., Matsuoka, K., Li, F., Karrasch, T., Uno, J. K., Sepulveda, A. R., Jobin, C., Baldwin, A. S., Robbins, P. D., Plevy, S. E. (2007). Amelioration of Chronic Murine Colitis by Peptide-Mediated Transduction of the I{kappa}B Kinase Inhibitor NEMO Binding Domain Peptide. J. Immunol. 179: 7852-7859 [Abstract] [Full Text]  
• Xia, Z.-W., Xu, L.-Q., Zhong, W.-W., Wei, J.-J., Li, N.-L., Shao, J., Li, Y.-Z., Yu, S.-C., Zhang, Z.-L. (2007). Heme Oxygenase-1 Attenuates Ovalbumin-Induced Airway Inflammation by Up-Regulation of Foxp3 T-Regulatory Cells, Interleukin-10, and Membrane-Bound Transforming Growth Factor- 1. Am. J. Pathol. 171: 1904-1914 [Abstract] [Full Text]  
• Beatty, P. L., Plevy, S. E., Sepulveda, A. R., Finn, O. J. (2007). Cutting Edge: Transgenic Expression of Human MUC1 in IL-10-/- Mice Accelerates Inflammatory Bowel Disease and Progression to Colon Cancer. J. Immunol. 179: 735-739 [Abstract] [Full Text]  
• Biteman, B., Hassan, I. R., Walker, E., Leedom, A. J., Dunn, M., Seta, F., Laniado-Schwartzman, M., Gronert, K. (2007). Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing. FASEB J. 21: 2257-2266 [Abstract] [Full Text]  
• Hu, C.-M., Lin, H.-H., Chiang, M.-T., Chang, P.-F., Chau, L.-Y. (2007). Systemic Expression of Heme Oxygenase-1 Ameliorates Type 1 Diabetes in NOD Mice. Diabetes 56: 1240-1247 [Abstract] [Full Text]  
• Cudmore, M., Ahmad, S., Al-Ani, B., Fujisawa, T., Coxall, H., Chudasama, K., Devey, L. R., Wigmore, S. J., Abbas, A., Hewett, P. W., Ahmed, A. (2007). Negative Regulation of Soluble Flt-1 and Soluble Endoglin Release by Heme Oxygenase-1. Circulation 115: 1789-1797 [Abstract] [Full Text]  
• Nielsen, V. G. (2007). Pharmacological Upregulation of Heme Oxygenase-1 Activity: A Novel Approach to the Treatment of Sepsis?. Anesth. Analg. 104: 258-259 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS